teva pharmaceuticals introduces the first generic glp-1 for weight loss FDA approval Teva introduces first U.S. generic

Ozempic and other drugs in the GLP-1 receptor agonist family have rapidly become famous for dramatic weight loss, but every few weeks it also seems we hear that social media users are shining a light on another new Ozempic side effect

In one study, people who practiced meditation for eight weeks reported a significant reduction in their sleep terror symptoms

MeAgain's GLP-1 app addresses the consistency challenge by combining medication tracking, meal logging, and progress monitoring on a single platform, reducing the friction of managing multiple tools while maintaining daily adherence to any GLP-1 treatment

Karagiannis T, Avgerinos I, Liakos A et al (2022) Management of type 2 diabetes with the dual GIP/GLP-1 receptor agonist tirzepatide: a systematic review and meta-analysis